A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis
Clinical trial NCT05539963 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05539963
- Sponsor
- Biocomposites Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2025-06-20
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.